Two different approaches to the nuclear SPECT camera market wereon display at the RSNA meeting last month. There was some debateat the show over the benefits of dedicated versus general-purposenuclear cameras. GE offered a fixed-detector dual-head SPECT
Two different approaches to the nuclear SPECT camera market wereon display at the RSNA meeting last month. There was some debateat the show over the benefits of dedicated versus general-purposenuclear cameras. GE offered a fixed-detector dual-head SPECT systemcalled Optima, dedicated for cardiac work.
"The needs of cardiac SPECT are such that if a hospitalcan justify a machine working almost entirely on cardiac procedures,a dedicated system makes sense," said John R. Haddock, vicepresident and general manager marketing and engineering for GEMedical Systems. "You optimize the design of the machinefor that application. It is also a simple design that costs less."
GE, which introduced its first triple-head camera--a dedicatedbrain unit--at the Society of Nuclear Medicine meeting earlierlast year, is also working on more general-purpose multi-headtechnology.
The vendor displayed information on a second dual-head systemunder development for whole-body applications. The unit will havea movable table that adds to scanning flexibility, Haddock said.
"This will be a very versatile unit. The heads can beset up to get a maximum field-of-view depending on whether youare trying to do whole-body or tomography," he said. GE shouldintroduce the second dual-head system sometime this year.
ADAC claimed at the RSNA meeting to have moved from the third-largestsupplier of SPECT cameras in the U.S. to first place last year,largely on the basis of its general-purpose dual-head Genesyscamera (see story, page 4).
"For the next few years, we believe leadership in thenuclear medicine market will go to whichever company can producecameras that can offer superior performance in more than justa single application," said ADAC president Stanley Czerwinski.
ADAC introduced a general-purpose, circular field-of-view cameraat the RSNA conference. The Cirrus camera has advanced engineeringbut retains the hands-on quality of a lower-end circular system,he said.
While it is robotically controlled, you can also walk up toit, grab hold and move the camera. It is simple to use,"he said.
ADAC licensed nuclear manufacturing rights last year and tookover inventory of circular field-of-view ARC 4000 cameras fromPhilips, which ceased new product development in nuclear medicine(SCAN 10/9/91). Cirrus, however, is largely based on technologydeveloped in-house, Czerwinski said.
ADAC will be putting a new camera into production every sixmonths for the next two years, he said.
Sopha introduced its variable-positioned dual-head SPECT system,the Sophycamera DSC, at last year's SNM exhibition and showedit again at the RSNA show. The camera heads can be angled forcardiac work or whole-body general imaging.
"Until this camera was shown, there was no camera thatcould provide both high cardiac efficiency and retain generalpurpose flexibility without a trade-off, said Randy Weatherhead,Sopha vice president of marketing.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.